These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 669573)
1. Effects of melatonin and natural and synthetic analogues of arginine vasotocin on plasma prolactin levels in adult male rats. Vaughan MK; Little JC; Johnson LY; Blask DE; Vaughan GM; Reiter RJ Horm Res; 1978; 9(4):236-46. PubMed ID: 669573 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of rat prolactin secretion in vivo by arginine vasotocin: influence of age of solution, nighttime administration, and dose. Vaughan MK; Little JC; Johnson LY; Vaughan GM; Reiter RJ Neuroendocrinology; 1977; 24(1):35-44. PubMed ID: 600363 [TBL] [Abstract][Full Text] [Related]
3. Interaction of luteinizing hormone-releasing hormone, cyproterone acetate and arginine vasotocin on plasma levels of luteinizing hormone in intact and castrated adult male rats. Vaughan MK; Trakulrungsi C; Petterborg LJ; Johnson LY; Blask DE; Trakulrungsi W; Reiter RJ Mol Cell Endocrinol; 1979 Apr; 14(1):59-71. PubMed ID: 378736 [TBL] [Abstract][Full Text] [Related]
4. The effect of subcutaneous injections of melatonin, arginine vasotocin, and related peptides on pituitary and plasma levels of luteinizing hormone, follicle-stimulating hormone, and prolactin in castrated adult male rats. Vaughan MK; Blask DE; Johnson LY; Reiter RJ Endocrinology; 1979 Jan; 104(1):212-7. PubMed ID: 446349 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent prolactin releasing activity of arginine vasotocin in intact and pinealectomized estrogen-progesterone treated adult male rats. Vaughan MK; Blask DE; Vaughan GM; Reiter RJ Endocrinology; 1976 Nov; 99(5):1319-22. PubMed ID: 991823 [TBL] [Abstract][Full Text] [Related]
6. Prolactin-releasing activity of arginine vasotocin in vitro. Vaughan MK; Blask DE; Johnson LY; Reiter RJ Horm Res; 1975; 6(5-6):342-50. PubMed ID: 1230425 [TBL] [Abstract][Full Text] [Related]
7. Evidence for prolactin-releasing and release-inhibiting effects of melatonin, serotonin and arginine vasotocin. Minato K; Takahashi K; Ikeno N; Watanabe M; Endo H; Yamamoto H Tohoku J Exp Med; 1983 Sep; 141(1):107-16. PubMed ID: 6636142 [TBL] [Abstract][Full Text] [Related]
8. Effect of several androgens, cyproterone acetate or estrogen-progesterone on the prolactin-releasing activity of arginine vasotocin in castrated male rats. Vaughan MK; Blask DE; Johnson LY; Trakulrungsi C; Reiter RJ Mol Cell Endocrinol; 1978 Dec; 12(3):309-18. PubMed ID: 738524 [TBL] [Abstract][Full Text] [Related]
9. Acute effects of arginine vasotocin on plasma and pituitary levels of prolactin in the male rat: influence of urethane anesthesia. Johnson LY; Vaughan MK; Reiter RJ; Petterborg LJ; Chen HJ Horm Res; 1980; 13(2):109-20. PubMed ID: 6785180 [TBL] [Abstract][Full Text] [Related]
10. Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat. Blask DE; Vaughan MK; Champney TH; Johnson LY; Vaughan GM; Becker RA; Reiter RJ Neuroendocrinology; 1984 Jan; 38(1):56-61. PubMed ID: 6694785 [TBL] [Abstract][Full Text] [Related]
11. Influence of estrogen and progesterone on the uterine sensitivity in vitro to neuropituitary hormones in the Brazilian marsupial Didelphis albiventris: comparison with lactating animals. Ladosky W; Calixto SL Gen Comp Endocrinol; 1984 Jan; 53(1):69-77. PubMed ID: 6325293 [TBL] [Abstract][Full Text] [Related]
12. [Effect of Asu-AVT on electroacupuncture (EA) analgesia]. Song C; Liu WY; Wang C; Lin B Zhen Ci Yan Jiu; 1992; 17(3):171-4. PubMed ID: 1339626 [TBL] [Abstract][Full Text] [Related]
13. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies. Blask DE; Vaughan MK; Reiter RJ; Johnson LY; Vaughan GM Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446 [TBL] [Abstract][Full Text] [Related]
14. Arginine vasotocin stimulates glucocorticoid secretion in male rats. Niles LP; Brown GM Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):841-4. PubMed ID: 6364237 [TBL] [Abstract][Full Text] [Related]
15. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. Feuerstein G; Zerbe RL; Faden AI J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114 [TBL] [Abstract][Full Text] [Related]
16. Effects of exogenous arginine vasotocin on circulating levels of thyroid hormones and melatonin in the pigeon, Columbia livia. John TM; George JC; Brown GM Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Nov; 112(3):345-51. PubMed ID: 8838688 [TBL] [Abstract][Full Text] [Related]
17. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro. Tiberiis BE; McLennan H; Wilson N Neuropeptides; 1983 Dec; 4(1):73-86. PubMed ID: 6669225 [TBL] [Abstract][Full Text] [Related]
18. Physiological effects of arginine vasotocin and mesotocin in cockerels. Robinzon B; Koike TI; Neldon HL; Kinzler SL; Hendry IR; el Halawani ME Br Poult Sci; 1988 Sep; 29(3):639-52. PubMed ID: 3224294 [TBL] [Abstract][Full Text] [Related]
19. A comparison of grooming behavior potencies of neurohypophyseal nonapeptides. Caldwell JD; Drago F; Prange AJ; Pedersen CA Regul Pept; 1986 May; 14(3):261-71. PubMed ID: 3014615 [TBL] [Abstract][Full Text] [Related]
20. Central cardiovascular effects of mammalian neurohypophyseal peptides in conscious rats. Zerbe RL; Kirtland S; Faden AI; Feuerstein G Peptides; 1983; 4(5):627-30. PubMed ID: 6657510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]